Research News
Researchers at SMHS found dermatologists are interested in learning more about and recommending therapeutic cannabinoids to patients.
Colin Young, PhD, received $2.4 million for his research on non-alcoholic fatty liver disease.
Researchers from the GW Cancer Center published in JAMA Dermatology on the efficacy of preventative strategies for adverse effects of taxane-based chemotherapy.
The study published in the Journal of Neuroscience suggests the thalamus controls the development of state dependency and continuity.
GW and the FDA published an update to the BioCompute Object Specification Project, which provides much-needed standards for communicating high-throughput sequencing computations and data analysis, known as BioCompute Objects.
The GW School of Medicine and Health Sciences is one of only two sites chosen for the first clinical trial of a HIV vaccine candidate.
Adam Friedman, MD, is the senior author of a study on the efficacy of nanoparticles in therapies for triple-negative breast cancer.
Rong Li, PhD, will serve as chair of the Department of Biochemistry and Molecular Medicine at the GW School of Medicine and Health Sciences.
The GW Postdoc Association hosted Postdoc Appreciation Day on Sept. 21 as part of the National Postdoc Association Postdoc Appreciation Week from Sept. 17–21.
Norman Lee, PhD, is investigating the mechanism behind dysregulation splicing factor expression.